These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Juvenile dermatomyositis: a case study. Schneider M; Murphy K J Pediatr Health Care; 2011; 25(1):38-43. PubMed ID: 21147406 [No Abstract] [Full Text] [Related]
45. Dermatomyositis presenting with severe subcutaneous edema: five additional cases and review of the literature. Milisenda JC; Doti PI; Prieto-González S; Grau JM Semin Arthritis Rheum; 2014 Oct; 44(2):228-33. PubMed ID: 24830790 [TBL] [Abstract][Full Text] [Related]
46. A case of juvenile dermatomyositis manifesting inflammatory epidermal nevus-like skin lesions: unrecognized cutaneous manifestation of blaschkitis? Takahashi Y; Murota H; Tarutani M; Sano S; Okinaga T; Tominaga K; Yano T; Katayama I Allergol Int; 2010 Dec; 59(4):425-8. PubMed ID: 20962570 [TBL] [Abstract][Full Text] [Related]
47. [New therapeutic approaches for polymyositis and dermatomyositis]. Dankó K; Vincze M Orv Hetil; 2011 Sep; 152(39):1552-9. PubMed ID: 21920841 [TBL] [Abstract][Full Text] [Related]
48. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases. Dinh HV; McCormack C; Hall S; Prince HM J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377 [TBL] [Abstract][Full Text] [Related]
49. [Dermatomyositis in children: study of seven cases]. Boukthir S; Ben Becheur S; Allani C; M'Rad S; Fetni I; Darragi M; Mongalgi MA; Zakraoui L; Debbabi A; Barsaoui S Tunis Med; 1999 Apr; 77(4):219-23. PubMed ID: 10392023 [No Abstract] [Full Text] [Related]
51. [Treatment of polymyositis and dermatomyositis]. Chérin P Rev Med Interne; 2004 Jun; 25 Suppl 1():S22-5. PubMed ID: 15165688 [No Abstract] [Full Text] [Related]
52. Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy. Williams L; Chang PY; Park E; Gorson KC; Bayer-Zwirello L Obstet Gynecol; 2007 Feb; 109(2 Pt2):561-3. PubMed ID: 17267895 [TBL] [Abstract][Full Text] [Related]
53. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment. Wu JQ; Lu MP; Reed AM World J Pediatr; 2020 Feb; 16(1):31-43. PubMed ID: 31556011 [TBL] [Abstract][Full Text] [Related]
54. Management of cutaneous dermatomyositis: current therapeutic options. Quain RD; Werth VP Am J Clin Dermatol; 2006; 7(6):341-51. PubMed ID: 17173468 [TBL] [Abstract][Full Text] [Related]
55. Intravenous immunoglobulin treatment in a girl with juvenile dermatomyositis. Kokori H; Fotoulaki M; Giannakopoulou C; Hatzidaki E; Tantros S; Sbyrakis S Pediatr Int; 1999 Dec; 41(6):696-7. PubMed ID: 10618894 [No Abstract] [Full Text] [Related]
56. Therapy for dermatomyositis and polymyositis. Rowland LP; Clark C; Olarte M Adv Neurol; 1977; 17():63-97. PubMed ID: 888742 [No Abstract] [Full Text] [Related]
57. A skin marker for geriatric cancer. Muelleman PJ; Perry HO Geriatrics; 1986 Apr; 41(4):49-54. PubMed ID: 3949166 [TBL] [Abstract][Full Text] [Related]
58. [Presentation of a case of dermatomyositis]. de Crousaz H; Juillard E; Bach J Rev Med Suisse Romande; 1977 Sep; 97(9):421-4. PubMed ID: 918451 [No Abstract] [Full Text] [Related]
59. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Feldman BM; Rider LG; Reed AM; Pachman LM Lancet; 2008 Jun; 371(9631):2201-12. PubMed ID: 18586175 [TBL] [Abstract][Full Text] [Related]
60. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr. McCann LJ; Juggins AD; Maillard SM; Wedderburn LR; Davidson JE; Murray KJ; Pilkington CA; Rheumatology (Oxford); 2006 Oct; 45(10):1255-60. PubMed ID: 16567354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]